Top Markets
#1 Helium Helium +56.02%
#2 TENDIES TENDIES +39.71%
#3 Seeker Seeker +25.85%
#4 Pons Pons +18.36%
#5 UnifAI Network UnifAI Network +13.62%
#6 Songbird Songbird +12.16%
#7 StonkBroker StonkBroker +10.86%
#8 OSK OSK +9.95%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +8.88%
#10 Audiera Audiera +8.46%
Coin of the day
Helium Helium
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
HK inno.N Corporation HK inno.N Corporation

HK inno.N Corporation

195940
Rang in Aktien #10328
Founded in 1984 and headquartered in Cheongju-si, South Korea, HK inno.N... Founded in 1984 and headquartered in Cheongju-si, South Korea, HK inno.N Corporation operates as a pharmaceutical enterprise. The company boasts a comprehensive portfolio of prescription medications designed to address a wide array of medical conditions. These include treatments for various infectious diseases, such as those caused by gram-positive and gram-negative bacteria, vancomycin-resistant Enterococcus faecium, acute bacterial sinusitis, bronchitis, and pneumonia. Their therapeutic offerings also extend to chronic illnesses like anemia, diabetes, hypertension (including cases with dyslipidemia), and hypercholesterolemia (covering primary and homozygous familial types), alongside solutions for hemodialysis. The firm develops drugs for gastrointestinal disorders such as GERD, EE, NERD, GU, and H. Pylori infections. In the oncology sector, HK inno.N provides treatments for non-small cell lung cancer, colorectal cancer, and both pleural and general mesothelioma. Additionally, they offer nutritional and intravenous therapeutic solutions. Beyond pharmaceuticals, the corporation supplies health and wellness products, including hangover relief drinks, ready-to-drink beverages, health supplements, functional foods, and active pharmaceutical ingredients. Its beauty division markets products under the bewants, ScalpMed, and KLEDERMA RX brands. The company maintains an international presence, exporting its diverse range of products to markets across Japan, Southeast Asia, Latin America, Europe, and the Middle East.
Aktienkurs
$30.18
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$855.10M
Veränderung (1 Tag)
1.39%
Veränderung (1 Jahr)
-12.84%
Land
KR
Handel HK inno.N Corporation (195940)

Kategorie

Healthcare
Gewinn für HK inno.N Corporation (195940)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von HK inno.N Corporation betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von HK inno.N Corporation von 2026 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
Nicht genügend Daten für die angegebenen Daten.
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
HCA Healthcare, Inc. HCA Healthcare, Inc.
HCA Healthcare, Inc.
HCA.US
$9.87B -
US
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA
FRE.DE
- -
DE
Dr. Sulaiman Al Habib Medical Services Group Company Dr. Sulaiman Al Habib Medical Services Group Company
Dr. Sulaiman Al Habib Medical Services Group Company
4013.SR
$687.82M -
SA
Tenet Healthcare Corporation Tenet Healthcare Corporation
Tenet Healthcare Corporation
THC.US
$3.87B -
US
IHH Healthcare Berhad IHH Healthcare Berhad
IHH Healthcare Berhad
5225.KL
- -
MY